Frontiers in Pharmacology·3 SepEfficacy and safety of Nefecon, glucocorticoids, or supportive therapyadded to RASi+SGLT2i in IgA nephropathyStudy in peopleInterventionsPaper
Clinical Nephrology·12 AugMechanisms and management of IgA nephropathy progression to end-stage renal disease: From the "four-hit" theory to precision medicineReviewMechanismsPaper